Cargando…

Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy

OBJECTIVE: To analyze the factors contributing to recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma (ESCC). METHODS: Patients with pT(3)N(0)M(0) thoracic ESCC who underwent esophagectomy from January 2008 to December 2012 were included retrospectively. The last da...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wei, Qi, Zhan, Qiu, Rong, Li, Zhen-Sheng, Dong, Shi-Lei, Li, Yue-Kao, Hu, Yuan-Ping, He, Ming, Wang, Yu-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727073/
https://www.ncbi.nlm.nih.gov/pubmed/33290111
http://dx.doi.org/10.1177/0300060520977403
_version_ 1783621024525320192
author Feng, Wei
Qi, Zhan
Qiu, Rong
Li, Zhen-Sheng
Dong, Shi-Lei
Li, Yue-Kao
Hu, Yuan-Ping
He, Ming
Wang, Yu-Xiang
author_facet Feng, Wei
Qi, Zhan
Qiu, Rong
Li, Zhen-Sheng
Dong, Shi-Lei
Li, Yue-Kao
Hu, Yuan-Ping
He, Ming
Wang, Yu-Xiang
author_sort Feng, Wei
collection PubMed
description OBJECTIVE: To analyze the factors contributing to recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma (ESCC). METHODS: Patients with pT(3)N(0)M(0) thoracic ESCC who underwent esophagectomy from January 2008 to December 2012 were included retrospectively. The last date of follow-up was 1 December 2016. Multivariate proportional hazard Cox models were used to identify factors associated with total (i.e., any) recurrence (TR), locoregional recurrence (LR), and distant metastasis (DM). RESULTS: A total of 692 patients were included. The median follow-up was 53 months (range: 3–107). The 3- and 5-year TR, LR, and DM rates were 35.8% and 41.0%, 28.7% and 32.1%, and 16.8% and 21.1%, respectively. The Cox analyses showed that the tumor location, number of dissected lymph nodes, and postoperative therapies were significantly associated with LR. The subgroup analysis showed that postoperative therapies could significantly decrease LR in the mediastinum but not in the neck and upper abdomen regions. CONCLUSIONS: The recurrence rate of pT(3)N(0)M(0) thoracic ESCC patients was high, especially for LR in the mediastinum. Postoperative therapies can significantly reduce the incidence of mediastinal recurrence.
format Online
Article
Text
id pubmed-7727073
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77270732020-12-18 Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy Feng, Wei Qi, Zhan Qiu, Rong Li, Zhen-Sheng Dong, Shi-Lei Li, Yue-Kao Hu, Yuan-Ping He, Ming Wang, Yu-Xiang J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To analyze the factors contributing to recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma (ESCC). METHODS: Patients with pT(3)N(0)M(0) thoracic ESCC who underwent esophagectomy from January 2008 to December 2012 were included retrospectively. The last date of follow-up was 1 December 2016. Multivariate proportional hazard Cox models were used to identify factors associated with total (i.e., any) recurrence (TR), locoregional recurrence (LR), and distant metastasis (DM). RESULTS: A total of 692 patients were included. The median follow-up was 53 months (range: 3–107). The 3- and 5-year TR, LR, and DM rates were 35.8% and 41.0%, 28.7% and 32.1%, and 16.8% and 21.1%, respectively. The Cox analyses showed that the tumor location, number of dissected lymph nodes, and postoperative therapies were significantly associated with LR. The subgroup analysis showed that postoperative therapies could significantly decrease LR in the mediastinum but not in the neck and upper abdomen regions. CONCLUSIONS: The recurrence rate of pT(3)N(0)M(0) thoracic ESCC patients was high, especially for LR in the mediastinum. Postoperative therapies can significantly reduce the incidence of mediastinal recurrence. SAGE Publications 2020-12-08 /pmc/articles/PMC7727073/ /pubmed/33290111 http://dx.doi.org/10.1177/0300060520977403 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Feng, Wei
Qi, Zhan
Qiu, Rong
Li, Zhen-Sheng
Dong, Shi-Lei
Li, Yue-Kao
Hu, Yuan-Ping
He, Ming
Wang, Yu-Xiang
Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title_full Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title_fullStr Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title_full_unstemmed Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title_short Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
title_sort risk factors for tumor recurrence in patients with pt(3)n(0)m(0) thoracic esophageal squamous cell carcinoma after esophagectomy
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727073/
https://www.ncbi.nlm.nih.gov/pubmed/33290111
http://dx.doi.org/10.1177/0300060520977403
work_keys_str_mv AT fengwei riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT qizhan riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT qiurong riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT lizhensheng riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT dongshilei riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT liyuekao riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT huyuanping riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT heming riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy
AT wangyuxiang riskfactorsfortumorrecurrenceinpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinomaafteresophagectomy